Basel Medical Group Ltd BMGL
Set alert
5.11 USD +0.07 +1.39%
At close · Nov 2
5.02 -0.09 -1.76%
After hours · Nov 2, 4:33 PM ET
4.95 Day range 5.16
2.56 52-week range 18.72
- YTD
- -13.10%
- 1 year
- -71.80%
- Open
- 5.00
- Prev close
- 5.04
- Mkt cap
- 69.40M
- Vol
- 1.88M
- Avg vol
- 850.53K
- EPS
- -4.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.95
- High
- 5.16
Financial health
Altman Z-Score
-1.19 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 3
Valuation
P/E -3.9×
FY 2021 5y median 48.9× FY 2024
P/S 3.8×
FY 2021 5y median 9.6× FY 2024
P/B 8.7×
FY 2021 5y median 15.4× FY 2024
P/FCF -9.7×
FY 2021 5y median 37.3× FY 2024
EV/EBITDA -3.9×
FY 2021 5y median 32.7× FY 2024
EV/Sales 3.8×
FY 2021 5y median 10.1× FY 2024
FCF Yield -10.4%
FY 2021 5y median 2.6% FY 2024
Profitability
Gross Margin 77.7%
FY 2021 5y median 77.7% FY 2024
Operating Margin -19.3%
FY 2021 5y median 21.2% FY 2024
Net Margin -106.8%
FY 2021 5y median 18.5% FY 2024
ROE -248.7%
FY 2021 5y median 30.0% FY 2024
ROIC -25.5%
FY 2021 5y median 14.0% FY 2024
ROA -71.7%
FY 2021 5y median 11.7% FY 2024
Growth (YoY)
Revenue 12.6%
FY 2021 FY 2024
Operating Income -199.4%
FY 2021 FY 2024
EPS (diluted) -555.6%
FY 2021 FY 2024
Free Cash Flow -275.9%
FY 2021 FY 2024
Financial Health
Current Ratio 1.2×
FY 2021 5y median 2.2× FY 2024
Quick Ratio 1.2×
FY 2021 5y median 2.2× FY 2024
Debt / Equity 0.7×
FY 2021 5y median 1.0× FY 2024
Net Debt / EBITDA -0.0×
FY 2021 5y median 1.4× FY 2024
Interest Coverage -10.7×
FY 2021 5y median 8.1× FY 2024
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2025-06-30